HANK & LIN'S GROUP

The past is prologue and the future is scintillating

18F-D3FSP（D3-AV45）
beta-Amyloid imaging for AD
18F-D3FSP（D3-AV45）
18F-D3FSP（D3-AV45）
18F-D6-AV133（D6-VMAT2）
VMAT2 imaging for PD
68Ga-PSMA 093（P16-093）
68Ga-PSMA 093（P16-093）
SCIENCE 2013
SCIENCE 2013
Chem Soc Review 2014
Chem Soc Review 2014
18F-Glutamine
18F-Glutamine
68Ga-Radiotracers
68Ga-Radiotracers
New Radiotracers
New Radiotracers
177Lu-PSMA 087/088
177Lu-PSMA 087/088
ISRS 2019
ISRS 2019
化学教育
化学教育
化学教育
化学教育
177Lu-Bone 073
177Lu-Bone 073
18F-PSMA 093
18F-PSMA 093

New Radiopharmaceuticals in clinical

 1.Prostate Cancer, PSMA:

Second Generation Theranostic agents:

   1)177Lu-P17-087；2)177Lu-P17-088           3)68Ga-P16-093（IND# 133222）

   4) 18F-AlF-P16-093

 2. Noval Theranostic Agents Targeting Bone Metastasis

    1) 68Ga-P15-041（IND #129870)

    2) 68Ga/177Lu-P15-073


 3.68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer

    1)68Ga/177Lu-AAZTA-NI-PSMA093

    2) 68Ga/177Lu-AAZTA-PSMA093

 4.68Ga/177Lu -Labeled Bivalent Agents for Targeting Hypoxia and FAPI-binding in Cancer

  1. 68Ga/177Lu-DOTA-NI-FAPI-04
  2. 68Ga/177Lu-AAZTA-NI-FAPI-04

7. [18F]F-D3FSP

（18F-P16-129，18F-D3-AV45）：

A new imaging agent of β-amyloid

plaques in the brain for diagnosis of Alzheimer's disease (AD)

（IND # 137713）

 5.68Ga/177Lu-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases 



J Med Chem. 2023 66 (17), 12602-12613

8. [18F]-D6-FP-DTBZ

(18F-P17-059，18F-D6-AV133):


A new VMAT2 imaging agent for PD

(IND # 138682)

 6. Metabolic imaging of glutamine in cancer


  1. [18F]-(2S,4R)4-Fluoroglutamine
  2. L-[5-11C]-glutamine


9. [18F]-FPBM2  :


SERT(5HTT) imaging agents


unsplash